Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease - PubMed (original) (raw)
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
E H Corder et al. Nat Genet. 1994 Jun.
Abstract
Gene dosage of the apolipoprotein E (APOE) epsilon 4 allele is a major risk factor for familial Alzheimer disease (AD) of late onset (after age 60). Here we studied a large series of 115 AD case subjects and 243 controls as well as 150 affected and 197 unaffected members of 66 AD families. Our data demonstrate a protective effect of the epsilon 2 allele, in addition to the dose effect of the epsilon 4 allele in sporadic AD. Although a substantial proportion (65%) of AD is attributable to the presence of epsilon 4 alleles, risk of AD is lowest in subjects with the epsilon 2/epsilon 3 genotype, with an additional 23% of AD attributable to the absence of an epsilon 2 allele. The opposite actions of the epsilon 2 and epsilon 4 alleles further support the direct involvement of APOE in the pathogenesis of AD.
Similar articles
- Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
Cui T, Zhou X, Jin W, Zheng F, Cao X. Cui T, et al. Chin Med J (Engl). 2000 Apr;113(4):340-4. Chin Med J (Engl). 2000. PMID: 11775232 - Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.
Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, et al. Saunders AM, et al. Neurology. 1993 Aug;43(8):1467-72. doi: 10.1212/wnl.43.8.1467. Neurology. 1993. PMID: 8350998 - Allele doses of apolipoprotein E type epsilon 4 in sporadic late-onset Alzheimer's disease.
Lucotte G, Aouizérate A, Gérard N, Turpin JC, Landais P. Lucotte G, et al. Am J Med Genet. 1995 Dec 18;60(6):566-9. doi: 10.1002/ajmg.1320600617. Am J Med Genet. 1995. PMID: 8825898 - [Alzheimer disease: hypotheses implicating apolipoproteins E].
Blain H, Merched A, Visvikis S, O'Kane M, Pillot T, Siest G, Jeandel C. Blain H, et al. Presse Med. 1996 May 4-11;25(16):763-8. Presse Med. 1996. PMID: 8692753 Review. French. - Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population.
Brayne C, Harrington CR, Wischik CM, Huppert FA, Chi LY, Xuereb JH, O'Connor DW, Paykel ES. Brayne C, et al. Dementia. 1996 May-Jun;7(3):169-74. doi: 10.1159/000106873. Dementia. 1996. PMID: 8740632 Review.
Cited by
- Apolipoprotein E and Alzheimer's Disease in Italian Population: Systematic Review and Meta-Analysis.
Abrego-Guandique DM, Saraceno GF, Cannataro R, Manzzo de Burnside M, Caroleo MC, Cione E. Abrego-Guandique DM, et al. Brain Sci. 2024 Sep 7;14(9):908. doi: 10.3390/brainsci14090908. Brain Sci. 2024. PMID: 39335404 Free PMC article. Review. - New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer's disease.
Cao Y, Zhao LW, Chen ZX, Li SH. Cao Y, et al. Front Neurosci. 2024 Sep 11;18:1430465. doi: 10.3389/fnins.2024.1430465. eCollection 2024. Front Neurosci. 2024. PMID: 39323915 Free PMC article. Review. - Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease.
Zota I, Chanoumidou K, Gravanis A, Charalampopoulos I. Zota I, et al. Front Cell Neurosci. 2024 Sep 2;18:1422130. doi: 10.3389/fncel.2024.1422130. eCollection 2024. Front Cell Neurosci. 2024. PMID: 39285941 Free PMC article. Review. - Updates in Alzheimer's disease: from basic research to diagnosis and therapies.
Liu E, Zhang Y, Wang JZ. Liu E, et al. Transl Neurodegener. 2024 Sep 4;13(1):45. doi: 10.1186/s40035-024-00432-x. Transl Neurodegener. 2024. PMID: 39232848 Free PMC article. Review. - Alzheimer's disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adults.
Soldan A, Wang J, Pettigrew C, Davatzikos C, Erus G, Hohman TJ, Dumitrescu L, Bilgel M, Resnick SM, Rivera-Rivera LA, Langhough R, Johnson SC, Benzinger T, Morris JC, Laws SM, Fripp J, Masters CL, Albert MS. Soldan A, et al. Brain Commun. 2024 Aug 14;6(5):fcae276. doi: 10.1093/braincomms/fcae276. eCollection 2024. Brain Commun. 2024. PMID: 39229494 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- U24 AG021886/AG/NIA NIH HHS/United States
- NIA AG05128/AG/NIA NIH HHS/United States
- NINDS NS26630/NS/NINDS NIH HHS/United States
- NINDS NS531153/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous